Cargando…

Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates

We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the plankton...

Descripción completa

Detalles Bibliográficos
Autores principales: Fauzia, Kartika Afrida, Miftahussurur, Muhammad, Syam, Ari Fahrial, Waskito, Langgeng Agung, Doohan, Dalla, Rezkitha, Yudith Annisa Ayu, Matsumoto, Takashi, Tuan, Vo Phuoc, Akada, Junko, Yonezawa, Hideo, Kamiya, Shigeru, Yamaoka, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472329/
https://www.ncbi.nlm.nih.gov/pubmed/32722296
http://dx.doi.org/10.3390/toxins12080473
_version_ 1783578963600211968
author Fauzia, Kartika Afrida
Miftahussurur, Muhammad
Syam, Ari Fahrial
Waskito, Langgeng Agung
Doohan, Dalla
Rezkitha, Yudith Annisa Ayu
Matsumoto, Takashi
Tuan, Vo Phuoc
Akada, Junko
Yonezawa, Hideo
Kamiya, Shigeru
Yamaoka, Yoshio
author_facet Fauzia, Kartika Afrida
Miftahussurur, Muhammad
Syam, Ari Fahrial
Waskito, Langgeng Agung
Doohan, Dalla
Rezkitha, Yudith Annisa Ayu
Matsumoto, Takashi
Tuan, Vo Phuoc
Akada, Junko
Yonezawa, Hideo
Kamiya, Shigeru
Yamaoka, Yoshio
author_sort Fauzia, Kartika Afrida
collection PubMed
description We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the planktonic susceptibility of 101 H. pylori strains. Biofilms were quantified by the crystal violet method. The minimum biofilm eradication concentration (MBEC) was obtained by measuring the survival of bacteria in a biofilm after exposure to antibiotics. The majority of the strains formed a biofilm (93.1% (94/101)), including weak (75.5%) and strong (24.5%) biofilm-formers. Planktonic resistant and sensitive strains produced relatively equal amounts of biofilms. The resistance proportion, shown by the MBEC measurement, was higher in the strong biofilm group for all antibiotics compared to the weak biofilm group, especially for clarithromycin (p = 0.002). Several cases showed sensitivity by the MIC measurement, but resistance according to the MBEC measurements (amoxicillin, 47.6%; tetracycline, 57.1%; clarithromycin, 19.0%; levofloxacin, 38.1%; and metronidazole 38.1%). Thus, biofilm formation may increase the survival of H. pylori and its resistance to antibiotics. Biofilm-related antibiotic resistance should be evaluated with antibiotic susceptibility.
format Online
Article
Text
id pubmed-7472329
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74723292020-09-04 Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates Fauzia, Kartika Afrida Miftahussurur, Muhammad Syam, Ari Fahrial Waskito, Langgeng Agung Doohan, Dalla Rezkitha, Yudith Annisa Ayu Matsumoto, Takashi Tuan, Vo Phuoc Akada, Junko Yonezawa, Hideo Kamiya, Shigeru Yamaoka, Yoshio Toxins (Basel) Article We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the planktonic susceptibility of 101 H. pylori strains. Biofilms were quantified by the crystal violet method. The minimum biofilm eradication concentration (MBEC) was obtained by measuring the survival of bacteria in a biofilm after exposure to antibiotics. The majority of the strains formed a biofilm (93.1% (94/101)), including weak (75.5%) and strong (24.5%) biofilm-formers. Planktonic resistant and sensitive strains produced relatively equal amounts of biofilms. The resistance proportion, shown by the MBEC measurement, was higher in the strong biofilm group for all antibiotics compared to the weak biofilm group, especially for clarithromycin (p = 0.002). Several cases showed sensitivity by the MIC measurement, but resistance according to the MBEC measurements (amoxicillin, 47.6%; tetracycline, 57.1%; clarithromycin, 19.0%; levofloxacin, 38.1%; and metronidazole 38.1%). Thus, biofilm formation may increase the survival of H. pylori and its resistance to antibiotics. Biofilm-related antibiotic resistance should be evaluated with antibiotic susceptibility. MDPI 2020-07-24 /pmc/articles/PMC7472329/ /pubmed/32722296 http://dx.doi.org/10.3390/toxins12080473 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fauzia, Kartika Afrida
Miftahussurur, Muhammad
Syam, Ari Fahrial
Waskito, Langgeng Agung
Doohan, Dalla
Rezkitha, Yudith Annisa Ayu
Matsumoto, Takashi
Tuan, Vo Phuoc
Akada, Junko
Yonezawa, Hideo
Kamiya, Shigeru
Yamaoka, Yoshio
Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title_full Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title_fullStr Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title_full_unstemmed Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title_short Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
title_sort biofilm formation and antibiotic resistance phenotype of helicobacter pylori clinical isolates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472329/
https://www.ncbi.nlm.nih.gov/pubmed/32722296
http://dx.doi.org/10.3390/toxins12080473
work_keys_str_mv AT fauziakartikaafrida biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT miftahussururmuhammad biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT syamarifahrial biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT waskitolanggengagung biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT doohandalla biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT rezkithayudithannisaayu biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT matsumototakashi biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT tuanvophuoc biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT akadajunko biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT yonezawahideo biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT kamiyashigeru biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates
AT yamaokayoshio biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates